Our Team
Dalgety brings together industry leaders, regulatory specialists and world leading experts in biochemistry and horticulture. Our forward-thinking team is dedicated to using innovation and technology to lead the way in medicinal cannabis production.
Main Board
Responsible for strategic & financial planning, compliance, reporting and governance.
David Waller
FIMC MBE (Chairman)
Former Senior Partner and Regional Chairman with PwC. Expertise in manufacturing and corporate finance. Previously held Director level commercial roles with global fmcg companies
James T Leavesley
DL
CEO of The Leavesley Group with extensive arable, growing & processing expertise working to GMP and GACP standards
John (Johnny) Leavesley
Qualified Lawyer and Contracts Expert
James D Leavesley
Operational & Facility Design Expertise. Former Markets & Trade Analyst
Rt Hon Jacqui Smith
Former Home Secretary and now Chair of a major NHS University Hospital Trust
Jane Sawyers
QPM DL Mst
Former Chief Constable and executive lead for drugs investigation & enforcement
Ian Greaves
FCA
Former KPMG Audit Partner specialising in mid-sized companies
Reeta Stokes
ACG
Company Secretary and formerly with St Modwen Properties and several FTSE 100 & 250 companies
Operating Board
Following the guidance of the Main Board, our Operational Board is responsible for the ongoing production, process management and quality control of our products. We have recruited international experts in the cultivation of medical cannabis, along with expert IT and system support, regulatory compliance and active research and development capability.
Dalgety are proud to lead the way in UK grown low carbon pharma grade cannabinoids. Our continued innovation and investment in technology will support the future development of the UK-Midlands as the leader for hydroponically grown medicinal cannabis.